Material Safety Data Sheet: STING-X II AEROSOL Supercedes Date 08/27/2001 Issuing Date 08/27/2008
Product Name STING-X II AEROSOL Product Code Recommended Use insecticide Chemical Nature Petroleum distillates Information on Manufacturer Emergency Telephone Number Emergency Overview Color Colorless Physical State Liquid Odor Petroleum distillates Potential Health Effects Principle Route of Exposure Primary Routes of Entry Acute Effects
May cause skin irritation. May cause allergic skin reaction.
Inhalation
May cause irritation of respiratory tract. Inhalation may cause central nervous system effects. Vapours may cause drowsiness and dizziness.
Ingestion
Ingestion may cause irritation to mucous membranes. Causes headache, drowsiness or other effects to the central nervous system. Aspiration hazard if swallowed - can enter lungs and cause damage. Harmful if swallowed.
Chronic Effects
Prolonged skin contact may defat the skin and produce dermatitis. Harmful if inhaled and may cause delayed lung injury. May cause skin sensitization in some individuals .
Target Organ Effects
Central nervous system, Cardiovascular system, Respiratory system, Bone Marrow.
Aggravated Medical Conditions
Skin disorders. Respiratory disorders. Neurological disorders.
Potential Environmental Effects
See Section 12 for additional Ecological information.
3. COMPOSITION / INFORMATION ON INGREDIENTS
Component
Petroleum distillates, hydrotreated light
General Advice
Avoid contact with skin, eyes and clothing. Avoid breathing vapors, mist or gas.
Eye Contact
Rinse thoroughly with plenty of water, also under the eyelids. Get medical attention if irritation develops and persists.
Skin Contact
Wash off immediately with soap and plenty of water. Remove contaminated clothing and shoes. Get medical attention if irritation develops and persists. Wash contaminated clothing before re-use.
Inhalation
Move to fresh air. In case of shortness of breath, give oxygen. If not breathing, give artificial respiration. Get medical attention if symptoms occur.
Ingestion
Drink 1 or 2 glasses of water. Do not induce vomiting. Get medical attention immediately. Never give anything by mouth to an unconscious person.
Notes to Physician
Aspiration hazard if swallowed - can enter lungs and cause damage.
Flash Point Autoignition Temperature No information available Flammability Limits in Air Mixture Upper 5.0 Lower 0.7 Suitable Extinguishing Media Water spray. Foam. Dry chemical. Carbon dioxide (CO2). Use:. Alcohol-resistant foam . Specific Hazards Arising from the Chemical Solvent vapors are heavier than air and may spread along floors . Vapors may ignite and explode. Material can create slippery conditions. Keep product and empty container away from heat and sources of ignition. Risk of ignition. Flame extension: >30 inches / >75 cm and Burnback: 0 inches / 0 cm . Protective Equipment and Precautions for Firefighters As in any fire, wear self-contained breathing apparatus pressure-demand, MSHA/NIOSH (approved or equivalent) and full protective gear. NFPA Flammability Instability Flammability Instability
Personal Precautions
Use personal protective equipment. Remove all sources of ignition. Ensure adequate ventilation. Prevent further leakage or spillage if safe to do so.
Environmental Precautions
Do not flush into surface water or sanitary sewer system.
Methods for Containment
Contain spillage, soak up with non-combustible absorbent material, (e.g. sand, earth, diatomaceous earth, vermiculite) and transfer to a container for disposal according to local / national regulations (see section 13)
Methods for Cleaning Up
Pick up and transfer to properly labelled containers. Never return spills in original containers for re-use.
Neutralizing Agent
Handling
Keep away from open flames, hot surfaces and sources of ignition. Avoid contact with skin, eyes and clothing. Avoid contact with skin and eyes. Avoid breathing vapors, mist or gas.
Keep container tightly closed in a dry and well-ventilated place. Keep away from heat and sources of ignition. Keep in properly labelled containers.
Storage Temperature Storage Conditions Refrigerated
8. EXPOSURE CONTROLS / PERSONAL PROTECTION
Exposure Guidelines Component ACGIH TLV
Petroleum distillates, hydrotreated light
Engineering Measures
Use with local exhaust ventilation. Ensure adequate ventilation, especially in confined areas.
Personal Protective Equipment
Eye/Face Protection Skin Protection Respiratory Protection
In case of inadequate ventilation wear respiratory protection.
General Hygiene Considerations
Ensure that eyewash stations and safety showers are close to the workstation location. Remove and wash contaminated clothing before re-use.
Physical State Viscosity Appearance Specific Gravity Bulk Density Evaporation Rate Percent Volatile (Volume) VOC Content (%) Vapor Pressure Vapor Density Solubility Boiling Point/Range
Chemical Stability
Stable. Hazardous polymerization does not occur .
Conditions to Avoid Incompatible Products Hazardous Decomposition Products Possibility of Hazardous Reactions
Component Information Acute toxicity Component LD50 Oral LD50 Dermal LC50 Inhalation Draize Test
Petroleum distillates, hydrotreated light
Chronic Toxicity Component Mutagenicity Sensitization Developmental Toxicity Reproductive Toxicity Target Organ Effects
Petroleum distillates, hydrotreated light
Carcinogenicity
The table below indicates whether each agency has listed any ingredient as a carcinogen.
Component
Petroleum distillates, hydrotreated light
Component Toxicity to Algae Toxicity to Fish Microtox Water Flea
LC50= 0.016 mg/L Pimephales promelas 96 h
Petroleum distillates, hydrotreated light
LC50= 1740 mg/L Lepomis macrochirus 96 h
Persistence and Degradability Bioaccumulation Mobility Product Disposal
Dispose of as hazardous waste in compliance with local and national regulations
Container Disposal
Empty containers should be taken for local recycling, recovery or waste disposal
Proper Shipping Name Hazard Class Description Proper shipping name Hazard Class Description Proper Shipping Name Hazard Class Shipping Description Proper Shipping Name Hazard Class Shipping Description IMDG/IMO
Proper Shipping Name Hazard Class Shipping Description
Inventories TSCA U.S. Federal Regulations SARA 313 Section 313 of Title III of the Superfund Amendments and Reauthorization Act of 1986 (SARA). This product contains a chemical or chemicals which are subject to the reporting requirements of the Act and and Title 40n of the Code of Federal Regulations, Part 372: Component SARA 313 - Threshold Values SARA 311/312 Hazardous Categorization Acute Health Hazard Chronic Health Hazard Fire Hazard Sudden Release of Pressure Reactive Hazard Component Hazardous Substances RQs CERCLA EHS RQs
Petroleum distillates, hydrotreated light
Canada Exempt WHMIS Hazard Class Not determined.
Prepared By Supercedes Date Issuing Date Reason for Revision Glossary List of References CERTIFIED LABS, DIV. OF NCH CORP. assumes no responsibility for personal injury or property damage caused by the use, storage, or disposal of the product in a manner not recommended on the product label. Users assume all risks associated wiht such unrecommended use, storage or disposal of the product. The information provided on this MSDS is correct to the best of our knowledge, information and belief at the date of its publication. The information given is designed only as a guide for safe handling, use, processing, storage, transportation, disposal and release and is not to be considered as a warranty or quality specification. The information relates only to the specific material designated and may not be valid for such material used in combination with any other material or in any process, unless specified in the text.
Research Report European Addiction Anxiety Disorders: Treatable regardless of the Severity of Comorbid Alcohol Dependence Annemiek Schadé a Loes A. Marquenie a Anton J.L.M. van Balkom a Maarten W.J. Koeter b Edwin de Beurs c Richard van Dyck a Wim van den Brink b a Department of Psychiatry and Institute for Extramural Medicine, VU University Medical Centre, GGZ-Buitenamstel,
Clin Rheumatol (2008) 27:739–742DOI 10.1007/s10067-007-0782-zRheumatoid arthritis in the United Arab EmiratesHumeira Badsha & Kok Ooi Kong & Paul P. TakReceived: 12 September 2007 / Revised: 10 October 2007 / Accepted: 14 October 2007 / Published online: 1 November 2007Abstract Studies have shown that patients with rheuma-were not on DMARD, only 28.1% had disease duration lesstoid